期刊
MOLECULAR PSYCHIATRY
卷 27, 期 1, 页码 81-87出版社
SPRINGERNATURE
DOI: 10.1038/s41380-021-01183-1
关键词
-
资金
- UK Medical Research Council [MR/S035591/1]
- Janssen Pharmaceuticals [MR/S035591/1]
This article summarizes the role of the habenula in regulating the expression of anhedonia and discusses the modulatory effect of ketamine on this circuitry. It suggests that experimental paradigms based on reinforcement learning and value-based decision-making can be useful in exploring this network to elucidate the mechanisms underlying ketamine's rapid antidepressant action.
Anhedonia, a pronounced reduction in interest or pleasure in any of life's daily activities, is a cardinal symptom of major depression. In this Perspective article, we synthesise the recent evidence from rodent, monkey and human neuroimaging literature to highlight how the habenula, a small evolutionarily conserved subcortical structure located in the midbrain, may orchestrate the behavioural expression of anhedonia across fronto-mesolimbic networks. We then review how this circuitry can be modulated by ketamine, an NMDA receptor antagonist with rapid antidepressant properties. We propose that experimental paradigms founded in reinforcement learning and value-based decision-making can usefully probe this network and thereby help elucidate the mechanisms underlying ketamine's rapid antidepressant action.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据